Sheikh, M., Cambre, E., Langreck, C., Javitch, J. A., & Canetta, S. E. (2025). Chronic administration of methocinnamox, a mu-opioid receptor antagonist, reduces hedonic response without impacting motivation in mice. Psychopharmacology. https://doi.org/10.1007/s00213-025-06801-2

Lawn, W., Hao, X., Konova, A. B., Haney, M., Cooper, Z. D., Van Dam, N., Glimcher, P., & Bedi, G. (2025). Value signals guiding choices for cannabis versus non-drug rewards in people who use cannabis near-daily. Psychopharmacology. https://doi.org/10.1007/s00213-025-06746-6

Chohan, M. O., Fein, H., Mirro, S., O’Reilly, K. C., & Veenstra-VanderWeele, J. (2023). Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors. Psychopharmacology, 240(12), 2545–2560. https://doi.org/10.1007/s00213-023-06448-x

Rosell, D. R., Slifstein, M., Thompson, J., Xu, X., Perez-Rodriguez, M. M., McClure, M. M., Hazlett, E. A., New, A. S., Nabulsi, N., Huang, Y., Carson, R. E., Siever, L. S., Abi-Dargham, A., & Koenigsberg, H. W. (2023). Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. Psychopharmacology, 240(2), 361–371. https://doi.org/10.1007/s00213-022-06306-2

Desrochers, S. S., Lesko, E. K., Magalong, V. M., Balsam, P. D., & Nautiyal, K. M. (2021). A role for reward valuation in the serotonergic modulation of impulsivity. Psychopharmacology, 238(11), 3293–3309. https://doi.org/10.1007/s00213-021-05944-2

Babalonis, S., Comer, S. D., Jones, J. D., Nuzzo, P., Lofwall, M. R., Manubay, J., Hatton, K. W., Whittington, R. A., & Walsh, S. L. (2021). Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes. Psychopharmacology, 238(9), 2503–2514. https://doi.org/10.1007/s00213-021-05872-1